NeuroNotis (TM), a new offering for hospital customers designed to bring greater confidence to Zeto ONE's AI-enabled seizure detection. The NeuroNotis Report confirms AI-generated seizure burden ...

NeuroNotis™, a new offering for hospital customers designed to bring greater confidence to Zeto ONE's AI-enabled seizure ...

A bar manager in Delhi has been booked for allegedly hosting dance performances without a valid licence. Police also seized ...

India and Uzbekistan launch DUSTLIK 2026 in Namangan, featuring joint combat drills, special operations, and a push for deeper military interoperability and strategic cooperation.

The rapid growth of digital markets and the use of artificial intelligence in business decision-making have fundamentally ...

The FDA issued a safety communication today warning of a potential increased risk of seizures tied to certain medications used to treat Parkinson's disease. The agency will require manufacturers of ...

Abstract: Epilepsy is a disease in which patients undergo seizures caused by brain functionality disorder. Clinically, it is usually diagnosed by experienced clinicians according to continuous ...

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients as it looks to position itself to become the ...

Epileptic seizures alter sleep by prolonging the stage that's central to memory formation, potentially predisposing the brain to "remember" how to trigger subsequent seizures more easily, a small ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests. The anti-seizure medication, levetiracetam, was first approved ...